Dosage & Administration Drug label Financial assistance

Praluent

(alirocumab)

Praluent 75 MG in 1 ML Auto-InjectorPraluent 150 MG in 1 ML Auto-Injector

NO BOXED WARNING

Dosage & administration

* In adults with established cardiovascular disease or with primary hyperlipidemia, including HeFH :
* The recommended starting dose of PRALUENT is either 75 mg once every 2 weeks or 300 mg once every 4 weeks administered subcutaneously.
* For patients receiving PRALUENT 300 mg every 4 weeks, measure LDL-C just prior to the next scheduled dose, because LDL-C can vary between doses in some patients.
* If the LDL-C response is inadequate, the dosage may be adjusted 150 mg subcutaneously every 2 weeks.

* In adults with HeFH undergoing LDL apheresis or in adults with HoFH :
* The recommended dose of PRALUENT is 150 mg once every 2 weeks administered subcutaneously.
* PRALUENT can be administered without regard to the timing of LDL apheresis.

* Assess LDL-C when clinically appropriate. The LDL-lowering effect of PRALUENT may be measured as early as 4 weeks after initiation.
* Administer PRALUENT subcutaneously into areas of the thigh, abdomen, or upper arm that are not tender, bruised, red, or indurated. Rotate injection sites for each administration.
* To administer the 300 mg dose, give two 150 mg PRALUENT injections consecutively at two different injection sites.

drug label

Praluent prescribing information

Contact Medical Science Liaison Report Adverse Event

financial assistance

Praluent financial assistance options

Co-pay savings program

commercial only

Enroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

patient education

Praluent patient education

Getting started on Praluent

Instructions For Use - 75 mg Pen: Risk Reduction Of Heart Attack, Stroke, & Angina; & Adjunct For Lowering LDL

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Instructions For Use - 150 mg Pen: Risk Reduction Of Heart Attack, Stroke, & Angina; & Adjunct For Lowering LDL

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

To share resource; ask patient to:

1.Pull out phone

2.Open camera

3.Scan QR code with camera

4.Tap link

Patient toolkit

About Praluent

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

View How to Take Praluent

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Patient Resources

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Patient Brochure

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Doctor Discussion Guide

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Learn More

Praluent FAQs

How is the dosage of Praluent?Praluent is available in 2 dosages, including 150 mg/ml Auto-Injector 1 ml and 75 mg/ml Auto-Injector 1 ml

What does Praluent treat?Praluent treats Hypercholesterolemia and Atherosclerosis

What is Praluent made of?Praluent contains alirocumab which is a PCSK9 Inhibitor

How Is Praluent Administered?Praluent is administered as a Injectable

What Are The Praluent Mechanism Of Action?Praluent mechanism of action is PCSK9 Inhibitors

FAQ Data Source

Praluent

Dosage & administration

drug label

Praluent prescribing information

financial assistance

Praluent financial assistance options

Co-pay savings program

patient education

Praluent patient education

Getting started on Praluent

Patient toolkit

people also ask

Praluent FAQs